» Articles » PMID: 35849255

Genomic Testing for Copy Number and Single Nucleotide Variants in Spermatogenic Failure

Overview
Publisher Springer
Date 2022 Jul 18
PMID 35849255
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To identify clinically significant genomic copy number (CNV) and single nucleotide variants (SNV) in males with unexplained spermatogenic failure (SPGF).

Materials And Methods: Peripheral blood DNA from 97/102 study participants diagnosed with oligozoospermia, severe oligozoospermia, or non-obstructive azoospermia (NOA) was analyzed for CNVs via array comparative genomic hybridization (aCGH) and SNVs using whole-exome sequencing (WES).

Results: Of the 2544 CNVs identified in individuals with SPGF, > 90% were small, ranging from 0.6 to 75 kb. Thirty, clinically relevant genomic aberrations, were detected in 28 patients (~ 29%). These included likely diagnostic CNVs in 3/41 NOA patients (~ 7%): 1 hemizygous, intragenic TEX11 deletion, 1 hemizygous DDX53 full gene deletion, and 1 homozygous, intragenic STK11 deletion. High-level mosaicism for X chromosome disomy (~ 10% 46,XY and ~ 90% 47,XXY) was also identified in 3 of 41 NOA patients who previously tested normal with conventional karyotyping. The remaining 24 CNVs detected were heterozygous, autosomal recessive carrier variants. Follow-up WES analysis confirmed 8 of 27 (30%) CNVs (X chromosome disomy excluded). WES analysis additionally identified 13 significant SNVs and/or indels in 9 patients (~ 9%) including X-linked AR, KAL1, and NR0B1 variants.

Conclusion: Using a combined genome-wide aCGH/WES approach, we identified pathogenic and likely pathogenic SNVs and CNVs in 15 patients (15%) with unexplained SPGF. This value equals the detection rate of conventional testing for aneuploidies and is considerably higher than the prevalence of Y chromosome microdeletions. Our results underscore the importance of comprehensive genomic analysis in emerging diagnostic testing of complex conditions like male infertility.

Citing Articles

Genetic variants in DDX53 contribute to autism spectrum disorder associated with the Xp22.11 locus.

Scala M, Bradley C, Howe J, Trost B, Salazar N, Shum C Am J Hum Genet. 2024; 112(1):154-167.

PMID: 39706195 PMC: 11739878. DOI: 10.1016/j.ajhg.2024.11.003.


Genetic variants in contribute to Autism Spectrum Disorder associated with the Xp22.11 locus.

Scala M, Bradley C, Howe J, Trost B, Salazar N, Shum C medRxiv. 2024; .

PMID: 38234782 PMC: 10793518. DOI: 10.1101/2023.12.21.23300383.


Semen Cryopreservation to Expand Male Fertility in Cancer Patients: Intracase Evaluation of Semen Quality.

Peluso G, Tisato V, Singh A, Gemmati D, Scarpellini F J Pers Med. 2023; 13(12).

PMID: 38138881 PMC: 10744704. DOI: 10.3390/jpm13121654.


Microdeletions and microduplications linked to severe congenital disorders in infertile men.

Kikas T, Punab A, Kasak L, Poolamets O, Vihljajev V, Pomm K Sci Rep. 2023; 13(1):574.

PMID: 36631630 PMC: 9834233. DOI: 10.1038/s41598-023-27750-w.

References
1.
Krausz C, Riera-Escamilla A . Genetics of male infertility. Nat Rev Urol. 2018; 15(6):369-384. DOI: 10.1038/s41585-018-0003-3. View

2.
Matzuk M, Lamb D . The biology of infertility: research advances and clinical challenges. Nat Med. 2008; 14(11):1197-213. PMC: 3786590. DOI: 10.1038/nm.f.1895. View

3.
Oud M, Volozonoka L, Smits R, Vissers L, Ramos L, Veltman J . A systematic review and standardized clinical validity assessment of male infertility genes. Hum Reprod. 2019; 34(5):932-941. PMC: 6505449. DOI: 10.1093/humrep/dez022. View

4.
Yatsenko A, Yatsenko S, Weedin J, Lawrence A, Patel A, Peacock S . Comprehensive 5-year study of cytogenetic aberrations in 668 infertile men. J Urol. 2010; 183(4):1636-42. PMC: 2969182. DOI: 10.1016/j.juro.2009.12.004. View

5.
Hardy J, Wyrwoll M, Mcfadden W, Malcher A, Rotte N, Pollock N . Variants in GCNA, X-linked germ-cell genome integrity gene, identified in men with primary spermatogenic failure. Hum Genet. 2021; 140(8):1169-1182. PMC: 8266742. DOI: 10.1007/s00439-021-02287-y. View